The NHANES is normally conducted every two years
Confirmatory secondary endpoints included 20%, 25%, and 30% weight loss, with all analyses performed on an intention-to-treat basis and reported with 95% confidence intervals
124 GLP-1, by activating its receptor, increases insulin secretion and reduces glucagon secretion, thereby lowering blood sugar levels
Eligible patients may self-administer GLOW Blend injections at home after receiving provider instructions and a personalized regimen
Emphasize the importance of holistic lifestyleencouraging regular movement, quality sleep, stress management, reduced substance use, and strong social connectionsto support overall well-being and long-term success